Title	Publication Date	Language	Citations
P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer	1994/01/01	English	108
Hippuric acid as a major excretion product associated with black tea consumption	2000/01/01	English	107
Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat	1999/01/01	English	105
Are free radicals involved in lead poisoning?	1991/01/01	English	104
Reduction of Azo Food Dyes in Cultures ofProteus vulgaris	1975/01/01	English	104
N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases	2011/03/24	English	104
Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potential	1999/01/01	English	104
Plasma concentrations of individual tea catechins after a single oral dose in humans	2001/01/01	English	104
The Fate of [14C]Phenol in Various Species	1972/01/01	English	103
Antioxidant and free radical scavenging activity of isoflavone metabolites	2003/09/01	English	103
Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450	2000/01/01	English	102
Studies on the Different Metabolic Pathways of Antipyrine in Rats: Influence of Phenobarbital and 3-Methylcholanthrene Treatment	1979/01/01	English	101
Metabolic disposition of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat, dog and man	2004/10/01	English	101
Cytochrome P450-dependent metabolism of gefitinib	2005/01/01	English	100
Evolution of the cytochrome P450 genes	1989/01/01	English	100
The pharmacokinetics of propofol in laboratory animals	1992/01/01	English	99
The Enzymic Formation of a Methylenedioxyphenyl Derivative Exhibiting an Isocyanide-like Spectrum with Reduced Cytochrome P-450 in Hepatic Microsomes	1971/01/01	English	98
The metabolism of14C-labelled trimethylamine and itsN-oxide in man	1987/01/01	English	98
Tissue disposition, excretion and metabolism of 2,2′,4,4′,5-pentabromodiphenyl ether (BDE-99) in the male Sprague-Dawley rat	2002/01/01	English	98
Effects of bioflavonoids on hepatic P450 activities	1995/01/01	English	98
Validation and application of Caco-2 assays for thein vitroevaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions	2008/08/01	English	97
Pharmacokinetics, disposition and biotransformation of [14C]-radiolabelled valsartan in healthy male volunteers after a single oral dose	1997/01/01	English	95
Algorithms for network analysis in systems-ADME/Tox using the MetaCore and MetaDrug platforms	2006/01/01	English	93
Baicalin, an emerging multi-therapeutic agent: pharmacodynamics, pharmacokinetics, and considerations from drug development perspectives	2010/03/15	English	93
Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells	1999/01/01	English	91
Biotransformation of Diclofenac Sodium (Voltaren®) in Animals and in Man.: II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile	1979/01/01	English	91
Mechanisms of Azo Reduction byStreptococcus faecalisII. The Role of Soluble Flavins	1971/01/01	English	91
Tissue distribution of drug-metabolizing enzymes in humans	1988/01/01	English	91
Accumulation and metabolism of drugs and CYP probe substrates in zebrafish larvae	2010/06/09	English	91
Effects of canthaxanthin, astaxanthin, lycopene and lutein on liver xenobiotic-metabolizing enzymes in the rat	1996/01/01	English	90